We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
(-5.9%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$25.4M |
| 2 |
AbbVie
ABBV
|
+$21.9M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$19.2M |
| 4 |
Waste Management
WM
|
+$19M |
| 5 |
Gilead Sciences
GILD
|
+$17.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$70.2M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
+$45.8M |
| 3 |
Biogen
BIIB
|
+$43.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.8M |
| 5 |
Amgen
AMGN
|
+$21.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.81% |
| 2 | Technology | 18.27% |
| 3 | Financials | 10.05% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Broadridge
BR
$17.2B
| – | – |
-17,437
| Closed | -$2.22M |
|
727
B2Gold
BTG
$5.16B
| – | – |
-258,377
| Closed | -$784K |
|
728
Compañía de Minas Buenaventura
BVN
$7.85B
| – | – |
-58,151
| Closed | -$965K |
|
729
Cars.com
CARS
$641M
| – | – |
-22,000
| Closed | -$432K |
|
730
Chubb
CB
$140B
| – | – |
-7
| Closed | -$1.03M |
|
731
Cracker Barrel
CBRL
$1.2B
| – | – |
-3,000
| Closed | -$510K |
|
732
Coty
COTY
$2.33B
| – | – |
-21,826
| Closed | -$291K |
|
733
Deckers Outdoor
DECK
$13.3B
| – | – |
-24,000
| Closed | -$701K |
|
734
Healthpeak Properties
DOC
$15.4B
| – | – |
-52,872
| Closed | -$1.68M |
|
735
EPR Properties
EPR
$4.86B
| – | – |
-7,000
| Closed | -$520K |
|
736
Equinor
EQNR
$95.9B
| – | – |
-144
| Closed | -$2.85M |
|
737
Eaton
ETN
$157B
| – | – |
-19
| Closed | -$1.58M |
|
738
Fluor
FLR
$7.29B
| – | – |
-22,023
| Closed | -$739K |
|
739
Fortuna Silver Mines
FSM
$2.59B
| – | – |
-230,753
| Closed | -$656K |
|
740
Gen Digital
GEN
$15.6B
| – | – |
-180,899
| Closed | -$3.92M |
|
741
Galicia Financial Group
GGAL
$7.92B
| – | – |
-262,000
| Closed | -$9.26M |
|
742
Globe Life
GL
$13.5B
| – | – |
-4,383
| Closed | -$3.34M |
|
743
Hain Celestial
HAIN
$47.8M
| – | – |
-24,000
| Closed | -$523K |
|
744
Honda
HMC
$36.5B
| – | – |
-98
| Closed | -$2.53M |
|
745
H&R Block
HRB
$5.18B
| – | – |
-16,081
| Closed | -$469K |
|
746
HSBC
HSBC
$355B
| – | – |
-61
| Closed | -$2.55M |
|
747
Integra LifeSciences
IART
$1.54B
| – | – |
-9,000
| Closed | -$500K |
|
748
ORIX
IX
$44B
| – | – |
-105
| Closed | -$1.57M |
|
749
iShares US Real Estate ETF
IYR
$4.59B
| – | – |
-82,781
| Closed | -$7.2M |
|
750
Jack in the Box
JACK
$278M
| – | – |
-5,000
| Closed | -$405K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2019 Portfolio in Review
As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.
- Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
- Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
- Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
- Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
- Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
- Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
- Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.
Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.